clinical trials tirzepatide CARDIOVASCULAR EFFICACY OF IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: AN INDIVIDUAL PARTICIPANT DATA META-ANALYSIS OF 8 RANDOMIZED Tirzepatide on ingestive behavior in

Delays gastric emptying reduces postprandial glucose 4

A new RAND report shows nearly 12% of U.S

Novo Nordisk's own product in India runs $94-277/month

We are now onboarding clients onto our weight loss program

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

We do not provide medical claims, therapeutic claims, dosage instructions, or end-user application guidance